The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F. Westendorp, Paul J. Nederkoorn, Vincent I.H. Kwa et al.|The Lancet|2015Cited by 328
Predicting Outcome in Guillain-Barré SyndromeAlex Y. Doets, Fábio Barroso, Hester F. Lingsma et al.|Neurology|2021Cited by 67
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré SyndromeHelle Al-Hakem, Fábio Barroso, Alex Y. Doets et al.|Neurology|2023Cited by 54